Join us for an in-person support group meeting hosted by Leah, one of our Oklahoma Support Group Leaders! If you are an individual diagnosed or a care partner for someone with ADEM, AFM, MOGAD, NMOSD, ON, or TM, we invite you to join us. Come connect with others and discuss what it’s like living with a rare neuroimmune disorder. Ask questions, share your stories, or just listen – everyone is welcome.
Join us for a casual gathering and lunch meeting of the Oklahoma SRNA Support Group. We meet on the second Saturday of each month at 2:00 p.m. For February, we are looking forward to a variety of high quality dishes at Johnnie’s Charcoal Broiler while
enjoying a great afternoon of connection. This will be a great opportunity to connect, catch up, and enjoy delicious barbecue while engaging in great conversation and company. Let us know you’ll be there by registering below.
COVID-19 Considerations
COVID-19 represents a real and significant risk to our community. If you or anyone in your household is experiencing symptoms or has tested positive we ask that you stay home. Masking is optional. If you develop symptoms following the event, please notify us at [email protected]. Please be advised that COVID-19 risks will not be completely eliminated. Even with every intention to minimize risks, SRNA realizes that every attendee must balance these issues and make their own decision regarding risks. On behalf of all in attendance, thank you for your understanding and cooperation.
SRNA 2025 education and support programs are supported by donations from our community and in part through grants from
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
* All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.